John Corbelli

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

Quality and reliability of information available on YouTube and Google pertaining gastroesophageal reflux disease

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Balloon pulmonary valvuloplasty: Results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry

Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Sex bias in neuroscience and biomedical research

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk

2007 Guidelines for the Management of Arterial Hypertension

Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

Type 2 diabetes

Balloon aortic valvuloplasty: Results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

Cardiovascular metabolic syndrome – an interplay of, obesity, inflammation, diabetes and coronary heart disease

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study)

New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?

Niacin therapy in atherosclerosis

Ezetimibe

Type 2 diabetes mellitus

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Markov Models in Medical Decision Making

Medication Adherence: WHO Cares?

Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials

Immunosuppressive Drugs for Kidney Transplantation

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Long-term clinical outcome after stent implantation in saphenous vein grafts

High-Density Lipoprotein Subfractions - What the Clinicians Need to Know

Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

Effect of high plant sterol-enriched diet and cholesterol absorption inhibitor, SCH 58235, on plant sterol absorption and plasma concentrations in hypercholesterolemic wild-type Kyoto rats

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome

Serious Gaps: How the Lack of Sex/Gender-Based Research Impairs Health

Pathophysiology of Human Visceral Obesity: An Update

Can Treatment Adherence Be Improved by Using Rubin's Four Tendencies Framework to Understand a Patient's Response to Expectations

Fluorine in medicinal chemistry

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

Dyslipidemia: Reduction in Estimated Risk for Coronary Artery Disease After Use of Ezetimibe with a Statin

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

Perspectives on low-density lipoprotein cholesterol goal achievement

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

Quality of Information in YouTube Videos on Erectile Dysfunction

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease

Niacin therapy in atherosclerosis

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Aortocoronary Saphenous Vein Graft Disease

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality

Predictors and Sequelae of Distal Embolization During Saphenous Vein Graft Intervention From the CAVEAT-II Trial

Preventing Restenosis With Fish Oils Following Coronary Angioplasty

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

The Metabolic Syndrome

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Myocardial Revascularization for Chronic Stable Angina

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Medication Adherence Measures: An Overview

Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia

Evaluation of YouTube as a reliable source for patient education on aortic valve stenosis

Peroxisome proliferator–activated receptor γ agonists for the Prevention of Adverse events following percutaneous coronary Revascularization—results of the PPAR Study

Efficacy of Extended-Release Niacin With Lovastatin for Hypercholesterolemia

Clinical outcome of “high-risk” vs “elective” patients undergoing percutaneous coronary intervention: Results from IMPACT-II

Percutaneous balloon valvuloplasty for congenital pulmonary valve stenosis

Gender bias in lipid assessment and treatment following percutaneous coronary intervention.

Follow-up after successful transluminal angioplasty: Report of the initial Cleveland Clinic experience

Percutaneous transluminal coronary angioplasty after previous coronary artery bypass surgery

Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population